Bevenopran

Bevenopran · Cubist Pharmaceuticals LLC (a subsidiary of Merck & Co.)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bevenopran, covering 2015-07-27 to 2015-07-27. Get the full timeline:

Most recent: Clinical Trial Update: Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment [Phase 1]